UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000060476
Receipt number	R000069060
Scientific Title	A Multicenter Retrospective Study on the Efficacy and Safety of First-Line Treatments (Nivolumab plus Cabozantinib and Pembrolizumab plus Lenvatinib) for Advanced/Metastatic Renal Cell Carcinoma
Date of disclosure of the study information	2026/01/27
Last modified on	2026/01/27 09:23:21

---